Exploring the Pharmacological Landscape of Undaria pinnatifida: Insights into Neuroprotective Actions and Bioactive Constituents
Open Access
- 24 July 2025
- journal article
- review article
- Published by MDPI AG in Nutraceuticals
- Vol. 5 (3) , 20
Abstract
The marine seaweed Undaria pinnatifida belongs to the large group of brown macroalgae (Ochrophyta) and is valued both as a nutritious food and a source of pharmaceutical compounds. It has been widely consumed in East Asia as part of the traditional diet and is generally regarded as a “healthy longevity food.” Consequently, it represents one of the most promising natural sources of biomedicinal and bioactive products. This review aims to synthesize current scientific evidence on the pharmacologically active compounds of U. pinnatifida, emphasizing their mechanisms of action and therapeutic potential in neurodegenerative and chronic diseases. This narrative review is based on a comprehensive literature search of peer-reviewed articles from scientific databases, focusing on studies addressing the pharmacological properties of U. pinnatifida and its major bioactive constituents. Recent research highlights that compounds such as fucoxanthin (a carotenoid), fucosterol (a sterol), fucoidan (a polysaccharide), alginate, and dietary fiber found in U. pinnatifida possess significant potential for developing treatments for conditions including goitre, urinary diseases, scrofula, dropsy, stomach ailments, and hemorrhoids. Moreover, these compounds exhibit remarkable pharmacological properties, including immunomodulation, antitumor, antiviral, antioxidant, antidiabetic, anti-inflammatory, anticoagulant, antithrombotic, and antibacterial activities, all with low toxicity and minimal side effects. Additionally, U. pinnatifida shows promise in the treatment or prevention of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, as well as neuropsychiatric conditions like depression, supported by its antioxidant effects against oxidative stress and neuroprotective activities. Numerous in vitro and in vivo studies have confirmed that U. pinnatifida polysaccharides (UPPs), particularly fucoidans, exhibit significant biological activities. Thus, accumulating evidence positions UPPs as promising therapeutic agents for a variety of diseases.Keywords
This publication has 146 references indexed in Scilit:
- The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative StudyArchivum Immunologiae et Therapiae Experimentalis, 2019
- Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegenerationSynapse, 2017
- An Antithrombotic Fucoidan, Unlike Heparin, Does Not Prolong Bleeding Time in a Murine Arterial Thrombosis Model: A Comparative Study of Undaria pinnatifida sporophylls and Fucus vesiculosusPhytotherapy Research, 2011
- Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeuticsJournal of Neural Transmission, 2011
- Toxicological evaluation of fucoidan from Undaria pinnatifidain vitro and in vivoPhytotherapy Research, 2010
- Antioxidant activities of sulfated polysaccharides from brown and red seaweedsJournal of Applied Phycology, 2006
- Structure and Antiviral Activity of the Galactofucan Sulfates Extracted from Undaria Pinnatifida (Phaeophyta)Journal of Applied Phycology, 2006
- Antiviral activity of Undaria pinnatifida against herpes simplex virusPhytotherapy Research, 2004
- GABA, ?-hydroxybutyric acid, and neurological diseaseAnnals of Neurology, 2003
- Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposureAnnals of Neurology, 1999